Mira Pharmaceuticals holds annual shareholder meeting with 63.06% of shares represented

Mira Pharmaceuticals held its 2026 annual shareholder meeting on Sept. 11, 2026.

• Shareholders backed the board’s slate of director nominees, setting their terms through the next annual meeting.
• Ratification of Salberg & Company, P.A. as independent auditor for the year ending Dec. 31, 2026 was approved.
• An adjournment authority to seek additional proxies if needed to secure support for the director slate or auditor ratification was authorized.